Mersana Therapeutics (MRSN) Short Interest Ratio & Short Volume $1.97 +0.07 (+3.68%) (As of 10/11/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Mersana Therapeutics Short Interest DataMersana Therapeutics (MRSN) has a short interest of 9.53 million shares. This marks a -7.57% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.2, indicating that it would take 8.2 days of the average trading volume of 1.69 million shares to cover all short positions.Current Short Interest9,530,000 sharesPrevious Short Interest10,310,000 sharesChange Vs. Previous Month-7.57%Dollar Volume Sold Short$18.01 millionShort Interest Ratio8.2 Days to CoverLast Record DateSeptember 30, 2024Outstanding Shares122,361,000 sharesPercentage of Shares Shorted7.79%Today's Trading Volume549,201 sharesAverage Trading Volume1,692,408 sharesToday's Volume Vs. Average32% Short Selling Mersana Therapeutics? Sign up to receive the latest short interest report for Mersana Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMRSN Short Interest Over TimeMRSN Days to Cover Over TimeMRSN Percentage of Float Shorted Over Time Ad Genesis Gold GroupKamala’s tax plan is worse than you think—find out whyBuffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Mersana Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/20249,530,000 shares $18.01 million -7.6%N/A8.2 $1.89 9/15/202410,310,000 shares $21.75 million +0.3%N/A8.8 $2.11 8/31/202410,280,000 shares $16.24 million +21.1%N/A8.4 $1.58 8/15/20248,490,000 shares $12.65 million -6.8%N/A6.2 $1.49 7/31/20249,110,000 shares $18.22 million -4.8%N/A6.1 $2.00 7/15/20249,570,000 shares $19.91 million -1.1%N/A6.2 $2.08 Get the Latest News and Ratings for MRSN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mersana Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 6/30/20249,680,000 shares $19.46 million -7.4%N/A5.9 $2.01 6/15/202410,450,000 shares $21.63 million -5.5%N/A6 $2.07 5/31/202411,060,000 shares $25.77 million +23.0%N/A5.8 $2.33 5/15/20248,990,000 shares $23.10 million -17.7%N/A4.2 $2.57 4/30/202410,920,000 shares $34.62 million +3.2%N/A5 $3.17 4/15/202410,580,000 shares $40.10 million +4.4%N/A4.8 $3.79 3/31/202410,130,000 shares $45.38 million +16.0%N/A4.3 $4.48 3/15/20248,730,000 shares $44.00 million +22.3%N/A3.8 $5.04 2/29/20247,140,000 shares $38.84 million +0.6%N/A3.4 $5.44 2/15/20247,100,000 shares $27.26 million +6.8%N/A3.6 $3.84 1/31/20246,650,000 shares $21.01 million -10.0%N/A3.5 $3.16 1/15/20247,390,000 shares $22.32 million -11.9%N/A3.6 $3.02 12/31/20238,390,000 shares $19.46 million -0.8%N/A4.1 $2.32 12/15/20238,460,000 shares $17.34 million -28.7%N/A4.3 $2.05 11/30/202311,870,000 shares $19.59 million -13.9%N/A5.4 $1.65 11/15/202313,790,000 shares $21.24 million +22.3%N/A6.6 $1.54 10/31/202311,280,000 shares $13.42 million +0.1%N/A5.2 $1.19 10/15/202311,270,000 shares $17.47 million +10.5%N/A1.7 $1.55 9/30/202310,200,000 shares $12.95 million -10.7%N/A1.6 $1.27 9/15/202311,420,000 shares $16.22 million +8.4%N/A1.8 $1.42 8/31/202310,540,000 shares $11.70 million -13.0%N/A1.4 $1.11 8/15/202312,120,000 shares $15.27 million -9.5%N/A1.7 $1.26 7/31/202313,390,000 shares $16.40 million +118.8%N/A1.8 $1.23 7/15/20236,120,000 shares $22.34 million -3.0%N/A1.9 $3.65 6/30/20236,310,000 shares $20.76 million +26.0%N/A2 $3.29 6/15/20235,010,000 shares $19.49 million -14.8%N/A1.7 $3.89 5/31/20235,880,000 shares $44.22 million -9.4%N/A3.1 $7.52 5/15/20236,490,000 shares $51.60 million -11.6%N/A3.6 $7.95 4/30/20237,340,000 shares $32.15 million +1.1%N/A4.3 $4.38 4/15/20237,260,000 shares $30.13 million -0.6%N/A5.8 $4.15 3/31/20237,300,000 shares $30.00 million +16.6%N/A5.6 $4.11 3/15/20236,260,000 shares $28.48 million -10.3%N/A4.8 $4.55 2/28/20236,980,000 shares $42.30 million +20.1%N/A5.9 $6.06 2/15/20235,810,000 shares $36.95 million +1.9%N/A5.1 $6.36Elon puts it all on the line… to save America (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, 1/31/20235,700,000 shares $37.51 million +9.2%N/A5.2 $6.58 1/15/20235,220,000 shares $31.63 million +3.6%N/A4.8 $6.06 12/30/20225,040,000 shares $29.53 million +11.8%N/A4.8 $5.86 12/15/20224,510,000 shares $31.12 million -5.1%N/A4.4 $6.90 11/30/20224,750,000 shares $31.64 million +0.4%N/A4.7 $6.66 11/15/20224,730,000 shares $32.73 million -12.4%N/A4.5 $6.92 10/31/20225,400,000 shares $42.44 million -6.3%N/A4.9 $7.86 10/15/20225,760,000 shares $37.90 million +7.9%N/A4.2 $6.58 9/30/20225,340,000 shares $36.10 million +38.0%N/A3.9 $6.76 9/15/20223,870,000 shares $29.57 million +8.4%N/A2.7 $7.64 8/31/20223,570,000 shares $26.78 million +3.2%N/A2.4 $7.50 8/15/20223,460,000 shares $26.68 million -9.9%N/A2.4 $7.71 7/31/20223,840,000 shares $19.47 million -19.5%N/A2.6 $5.07 7/15/20224,770,000 shares $26.86 million -19.6%N/A4 $5.63 6/30/20225,930,000 shares $27.40 million -1.3%N/A4.2 $4.62 6/15/20226,010,000 shares $19.05 million +2.4%N/A4.1 $3.17 5/31/20225,870,000 shares $19.61 million +26.5%N/A4 $3.34 5/15/20224,640,000 shares $13.83 million +8.4%N/A3 $2.98 4/30/20224,280,000 shares $14.89 million +23.7%N/A2.4 $3.48 4/15/20223,460,000 shares $16.99 million -3.4%N/A1.8 $4.91 3/31/20223,580,000 shares $14.28 million -24.2%N/A1.9 $3.99 3/15/20224,720,000 shares $18.46 million +9.8%N/A2.7 $3.91 2/28/20224,300,000 shares $18.88 million +2.4%N/A2.7 $4.39 2/15/20224,200,000 shares $17.26 million -25.3%6.9%2.6 $4.11 1/31/20225,620,000 shares $26.81 million +14.2%9.1%4.1 $4.77 1/15/20224,920,000 shares $30.90 million +13.6%8.0%4.9 $6.28 12/31/20214,330,000 shares $26.93 million +1.4%7.0%4.7 $6.22 12/15/20214,270,000 shares $24.55 million No Change6.7%5.8 $5.75 11/30/20214,270,000 shares $28.78 million -1.4%6.7%5.1 $6.74 11/15/20214,330,000 shares $38.75 million -13.2%6.8%5.4 $8.95 10/29/20214,990,000 shares $42.71 million -4.0%7.9%6.6 $8.56 10/15/20215,200,000 shares $44.15 million -1.0%8.2%6.4 $8.49 9/30/20215,250,000 shares $49.51 million +1.4%8.3%7 $9.43 9/15/20215,180,000 shares $46.62 million -6.8%8.2%6.6 $9.00 8/31/20215,560,000 shares $77.45 million -12.7%8.8%7.7 $13.93 8/13/20216,370,000 shares $77.52 million -6.9%10.1%10.7 $12.17 7/30/20216,840,000 shares $75.24 million -1.6%11.0%11.2 $11.00 7/15/20216,950,000 shares $87.29 million -6.3%10.8%12.5 $12.56 6/30/20217,420,000 shares $100.76 million -14.0%11.6%12.9 $13.58 6/15/20218,630,000 shares $126.00 million +2.1%13.4%13.9 $14.60 5/28/20218,450,000 shares $121.00 million -2.7%13.2%14.4 $14.32 5/14/20218,680,000 shares $124.56 million +5.0%N/A13.5 $14.35 4/30/20218,270,000 shares $137.12 million -3.8%N/A12.1 $16.58 4/15/20218,600,000 shares $147.40 million -12.3%N/A11.3 $17.14 3/31/20219,810,000 shares $150.19 million +13.8%N/A11 $15.31 3/15/20218,620,000 shares $155.16 million -1.9%N/A7.8 $18.00 2/26/20218,790,000 shares $161.47 million +3.5%N/A7.7 $18.37 2/12/20218,490,000 shares $194.93 million +3.4%N/A7.4 $22.96 1/29/20218,210,000 shares $152.95 million +2.5%N/A7 $18.63 1/15/20218,010,000 shares $166.29 million +6.9%N/A7 $20.76Elon puts it all on the line… to save America (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, 12/31/20207,490,000 shares $199.08 million +11.5%N/A7.2 $26.58 12/15/20206,720,000 shares $171.49 million -5.0%N/A8.2 $25.52 11/30/20207,070,000 shares $177.53 million +1.6%N/A6.7 $25.11 11/15/20206,960,000 shares $156.88 million +6.6%N/A7.1 $22.54 10/30/20206,530,000 shares $116.76 million -4.5%N/A7 $17.88 10/15/20206,840,000 shares $130.71 million +2.2%N/A7.5 $19.11 9/30/20206,690,000 shares $124.57 million +19.0%N/A7.3 $18.62 9/15/20205,620,000 shares $128.75 million -3.8%N/A5.7 $22.91 8/31/20205,840,000 shares $111.89 million No ChangeN/A7.5 $19.16 8/14/20205,840,000 shares $108.51 million +20.9%N/A3.1 $18.58 7/31/20204,830,000 shares $96.02 million +5.9%N/A2.6 $19.88 7/15/20204,560,000 shares $103.06 million +1.1%N/A2.4 $22.60 6/30/20204,510,000 shares $105.53 million +47.9%N/A2.2 $23.40 6/15/20203,050,000 shares $64.66 million -17.8%N/A1.4 $21.20 5/29/20203,710,000 shares $73.05 million +49.6%N/A1.8 $19.69 5/15/20202,480,000 shares $24.82 million +4.2%5.4%1.5 $10.01 4/30/20202,380,000 shares $21.49 million +2.6%5.6%2.4 $9.03 4/15/20202,320,000 shares $19.77 million -0.4%6.8%2.6 $8.52 3/31/20202,330,000 shares $21.09 million -4.4%7.2%2.8 $9.05 3/13/20202,438,200 shares $22.99 million -5.1%7.8%6.1 $9.43 2/28/20202,570,000 shares $13.36 million +8.9%8.2%5.8 $5.20 2/14/20202,360,000 shares $16.73 million +3.5%6.8%5.6 $7.09 1/31/20202,280,000 shares $21.16 million +26.7%7.1%5.7 $9.28 1/15/20201,800,000 shares $14.00 million +68.2%5.6%4.7 $7.78 12/31/20191,070,000 shares $7.94 million +29.5%3.3%3.4 $7.42 MRSN Short Interest - Frequently Asked Questions What is Mersana Therapeutics' current short interest? Short interest is the volume of Mersana Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 9,530,000 shares of MRSN short. Learn More on Mersana Therapeutics' current short interest. What is a good short interest ratio for Mersana Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRSN shares currently have a short interest ratio of 8.0. Learn More on Mersana Therapeutics's short interest ratio. Is Mersana Therapeutics' short interest increasing or decreasing? Mersana Therapeutics saw a decrease in short interest in the month of September. As of September 30th, there was short interest totaling 9,530,000 shares, a decrease of 7.6% from the previous total of 10,310,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mersana Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Mersana Therapeutics: Immatics (11.24%), Cullinan Therapeutics, Inc. (23.62%), ArriVent BioPharma, Inc. (17.28%), Sana Biotechnology, Inc. (25.89%), AnaptysBio, Inc. (23.08%), Prothena Co. plc (9.86%), Phibro Animal Health Co. (1.96%), Applied Therapeutics, Inc. (10.76%), CARGO Therapeutics, Inc. (16.05%), IGM Biosciences, Inc. (19.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks. What does it mean to sell short Mersana Therapeutics stock? Short selling MRSN is an investing strategy that aims to generate trading profit from Mersana Therapeutics as its price is falling. MRSN shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mersana Therapeutics? A short squeeze for Mersana Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRSN, which in turn drives the price of the stock up even further. How often is Mersana Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRSN, twice per month. The most recent reporting period available is September, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Immatics Short Interest Data Cullinan Therapeutics Short Interest Data ArriVent BioPharma Short Interest Data Sana Biotechnology Short Interest Data AnaptysBio Short Interest Data Prothena Short Interest Data Phibro Animal Health Short Interest Data Applied Therapeutics Short Interest Data CARGO Therapeutics Short Interest Data IGM Biosciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRSN) was last updated on 10/12/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredAI Expert Reveals New PickYour Financial Planner Won't Tell You About This Investment Strategy Silicon Valley insider Jeff Brown has ...Brownstone Research | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe Great Crypto Frenzy 2.0 is About to StartBitcoin’s Final Bull Run: Three Altcoins to Get Into NOW! “Crypto Whisperer” Ian King is calling it: due to...Banyan Hill Publishing | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredTiny Defense Firm Set for Huge Gains with New US ContractOne tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mersana Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mersana Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.